Cargando…
Th17 cells over 5.9% at admission indicate poor prognosis in patients with HBV-related acute-on-chronic liver failure
Our previous study demonstrated that Th17 cells increased significantly in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). However, their prognostic role in HBV-ACLF patients remains unknown. Sixty-eight consecutive HBV-ACLF patients were enrolled in this cohort st...
Autores principales: | Zhang, Geng-lin, Zhang, Ting, Zhao, Qi-yi, Lin, Chao-shuang, Gao, Zhi-liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200497/ https://www.ncbi.nlm.nih.gov/pubmed/30290645 http://dx.doi.org/10.1097/MD.0000000000012656 |
Ejemplares similares
-
Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
por: Chen, Peng, et al.
Publicado: (2019) -
Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia
por: Han, Yixiang, et al.
Publicado: (2014) -
Elevated Serum IgG Levels Positively Correlated with IL-27 May Indicate Poor Outcome in Patients with HBV-Related Acute-On-Chronic Liver Failure
por: Zhang, Geng-lin, et al.
Publicado: (2019) -
Th1(high) in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC
por: Jian, Huang, et al.
Publicado: (2017) -
Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis
por: Yang, Shanshan, et al.
Publicado: (2022)